Lack of complications in minor skin lesion excisions in patients taking aspirin or warfarin products

American Surgeon

Volumn 74, Issue 4, 2008, Pages 354-357

  Shalom, Avshalom ^a,b   Klein, Doron ^a,b   Friedman, Tal ^a,b   Westreich, Melvyn ^a,b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ARTICLE; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; DRUG USE; FEMALE; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MINOR SURGERY; SKIN DEFECT; SKIN FLAP; SKIN GRAFT; SKIN SURGERY;

AGED; ANTICOAGULANTS; ASPIRIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; SKIN DISEASES; SURGICAL WOUND DEHISCENCE; WARFARIN;

EID: 41749099069     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kovich O, Otley CC. Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation. J Am Acad Dermatol 2003;48:233-7.
2. Chan AT, Giovannucci EL, Meyerhardt JA, et al. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 2005;294:914-23.
3. Harris RE, Beebe-Donk J, Alshafie GA. Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer 2006;30:27.
4. Mahmud SM, Tanguay S, Begin LR, et al. Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population. Eur J Cancer Prev 2006;15:158-64.
5. Kimmey MB. Cardioprotective effects and gastrointestinal risks of aspirin: Maintaining the delicate balance. Am J Med 2004;117(Suppl 5A):72S-8S.
6. The SALT Collaborative Group. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 1991;338:1345-9.
7. Morawski W, Sanak M, Cisowski M, et al. Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: Role of aspirin and platelet glycoprotein Ilia polymorphism. J Thorac Cardiovasc Surg 2005;130:791-6.
8. Reich DL, Patel GC, Vela-Cantos F, et al. Aspirin does not increase homologous blood requirements in elective coronary bypass surgery. Anesth Analg 1994;79:4-8.
9. Michelson EL, Morganroth J, Torosian M, MacVaugh H III. Relation of preoperative use of aspirin to increased mediastinal blood loss after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 1978;76:694-7.
10. Flordal PA. Pharmacological prophylaxis of bleeding in surgical patients treated with aspirin. Eur J Anaesthesiol Suppl 1997;14:38-41.
11. Sethi GK, Copeland JG, Goldman S, et al. Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy. J Am Coll Cardiol 1990;15:15-20.
12. Torosian M, Michelson EL, Morganroth J, Mac Vaugh H III. Aspirin- and Coumadin-related bleeding after coronary-artery bypass graft surgery. Ann Intern Med 1978;89:325-8.
13. Ala-Opas MY, Gronlund SS. Blood loss in long-term aspirin users undergoing transurethral prostatectomy. Scand J Urol Nephrol 1996;30:203-6.
14. Thurston AV, Briant SL. Aspirin and post-prostatectomy haemorrhage. Br J Urol 1993;71:574-6.
15. Wierod FS, Frandsen NJ, Jacobsen JD, et al. Risk of haemorrhage from transurethral prostatectomy in acetylsalicylic acid and NSAID-treated patients. Scand J Urol Nephrol 1998;32:120-2.
16. Manning BJ, O'Brien N, Aravindan S, et al. The effect of aspirin on blood loss and transfusion requirements in patients with femoral neck fractures. Injury 2004;35:121-4.
17. Narendran N, Williamson TH. The effects of aspirin and warfarin therapy on haemorrhage in vitreoretinal surgery. Acta Ophthalmol Scand 2003;81:38-40.
18. Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005;353:2373-83.
19. Malacaria B, Feloney CD. Going with the flow of anticoagulant therapy. Nursing 2003;33:36-42; quiz 43-4.
20. Dietrich W, Dilthey G, Spannagl M, Richter JA. Warfarin pretreatment does not lead to increased bleeding tendency during cardiac surgery. J Cardiothorac Vasc Anesth 1995;9:250-4.
21. Giudici MC, Paul DL, Bontu P, Barold SS. Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy. Pacing Clin Electrophysiol 2004;27:358-60.
22. Smit A, Hooper G. Elective hand surgery in patients taking warfarin. J Hand Surg [Br] 2004;29:206-7.
23. Wallace DL, Latimer MD, Belcher HJ. Stopping warfarin therapy is unnecessary for hand surgery. J Hand Surg [Br] 2004;29:203-5.
24. Varkarakis IM, Rais-Bahrami S, Allaf ME, et al. Laparoscopic renal-adrenal surgery in patients on oral anticoagulant therapy. J Urol 2005;174:1020-3.
25. Ihezue CU, Smart J, Dewbury KC, et al. Biopsy of the prostate guided by transrectal ultrasound: Relation between warfarin use and incidence of bleeding complications. Clin Radiol 2005;60:459-63.
26. Cannon PD, Dharmar VT. Minor oral surgical procedures in patients on oral anticoagulants - A controlled study. Aust Dent J 2003;48:115-8.
27. Bell DF, Harris WH, Kuter DJ, Wessinger SJ. Elevated partial thromboplastin time as an indicator of hemorrhagic risk in postoperative patients on warfarin prophylaxis. J Arthroplasty 1988;3:181-4.
28. Johnson WC, Williford WO, Corson JD, Padberg FT Jr. Hemorrhagic complications during long-term postoperative warfarin administration in patients undergoing lower extremity arterial bypass surgery. Vascular 2004;12:362-8.
29. Hui AJ, Wong RM, Ching JY, et al. Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: Analysis of 1657 cases. Gastrointest Endosc 2004;59:44-8.
30. Bartlett GR. Does aspirin affect the outcome of minor cutaneous surgery? Br J Plast Surg 1999;52:214-6.
31. Billingsley EM, Maloney ME. Intraoperative and postoperative bleeding problems in patients taking warfarin, aspirin, and nonsteroidal antiinflammatory agents. A prospective study. Dermatol Surg 1997;23:381-3.
32. Kargi E, Babuccu O, Hosnuter M, et al. Complications of minor cutaneous surgery in patients under anticoagulant treatment. Aesthetic Plast Surg 2002;26:483-5.
33. Otley CC, Fewkes JL, Frank W, Ulbricht SM. Complications of cutaneous surgery in patients who are taking warfarin, aspirin, or nonsteroidal anti-inflammatory drugs. Arch Dermatol 1996;132:161-6.
34. Alcalay J, Alkalay R. Controversies in perioperative management of blood thinners in dermatologic surgery: Continue or discontinue? Dermatol Surg 2004;30:1091-4.
35. Lawrence C, Sakuntabhai A, Tiling-Grosse S. Effect of aspirin and nonsteroidal antiinflammatory drug therapy on bleeding complications in dermatologic surgical patients. J Am Acad Dermatol 1994;31:988-92.
36. Otley CC. Continuation of medically necessary aspirin and warfarin during cutaneous surgery. Mayo Clin Proc 2003;78:1392-6.